MoneyWorks4Me

Aurobindo Pharma informs about analysts presentation

24 Aug 2016 Evaluate

Aurobindo Pharma has submitted a copy of the presentation to the Investors/Analysts on the Unaudited Financial Results of the Company for the first quarter ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..